Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature (Q38205761)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 March 2014

edit

Language	Label	Description	Also known as
English	Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature	scientific article published on 31 March 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

case report

0 references

title

Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

main subject

case report

1 reference

based on heuristic

inferred from title

bullous pemphigoid

1 reference

based on heuristic

inferred from title

author name string

Amy Attaway

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

Tracey L Mersfelder

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

Sakshi Vaishnav

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

Joanne K Baker

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

publication date

31 March 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

published in

Journal of dermatological case reports

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

volume

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

page(s)

24-28

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

cites work

Dipeptidyl peptidase in autoimmune pathophysiology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

The pathophysiology of bullous pemphigoid

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

Cytokines and bullous pemphigoid

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

A method for estimating the probability of adverse drug reactions

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

6 September 2017

Drug-induced bullous pemphigoid

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

28 September 2017

Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

23 June 2018

Drug‐induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase‐IV inhibitors plus metformin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

31 August 2018

Sitagliptin-associated drug allergy: review of spontaneous adverse event reports

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

31 August 2018

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

31 August 2018

Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3989094

retrieved

31 August 2018

Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs associated with bullous pemphigoid. A case-control study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24748908

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.3315/JDCR.2014.1166

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

PMC publication ID

3989094

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

PubMed publication ID

24748908

1 reference

stated in

Europe PubMed Central

PMC publication ID

3989094

retrieved

31 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38205761&oldid=1747146564"